[Uveitis treatment].
D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum; D001623:Betamethasone / Q000627:therapeutic use; D003228:Conjunctiva; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007267:Injections; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D011677:Punctures; D012216:Rheumatic Diseases / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications; D014605:Uveitis / Q000209:etiology / Q000601:surgery / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D003348:Cortisone
Le traitement des uvéites.